drugset / Trial / NCT04954534
Exploratory Efficacy Study of NEUROSTEM® in Subjects Who Control Group of NEUROSTEM®
NaSingle-groupOpen-labelTreatment
Summary
This study is to evaluate of Exploratory Efficacy of NEUROSTEM® in Subjects who control group of NEUROSTEM® Phase-I/IIa Clinical Trial
Timeline
- Start
- 2021-07-12
- Primary completion
- 2022-01-31
- Completion
- 2022-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | human umbilical cord blood derived mesenchymal stem cells | Cell therapy | 2 ml | Other |
| Subject | human umbilical cord blood derived mesenchymal stem cells | Cell therapy | 3e+07 cells | Other |